Prognostic implications of left ventricular hypertrophy

Clement, 1993, Left ventricular function and regression of left ventricular hypertrophy in essential hypertension, Am J Hypertens, 6, 14, 10.1093/ajh/6.3.14S

Levy, 1988, Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study, Ann Intern Med, 108, 7, 10.7326/0003-4819-108-1-7

Hammond, 1986, The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension, J Am Coll Cardiol, 7, 639, 10.1016/S0735-1097(86)80476-4

Savage, 1979, Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects, Circulation, 59, 623, 10.1161/01.CIR.59.4.623

Verdecchia, 1998, Prognostic significance of serial changes in left ventricular mass in essential hypertension, Circulation, 97, 48, 10.1161/01.CIR.97.1.48

Kannel, 1986, A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study, Am Heart J, 111, 391, 10.1016/0002-8703(86)90156-0

Boden, 1988, Clinical significance and prognostic importance of left ventricular hypertrophy in nonQ-wave acute myocardial infarction, Am J Cardiol, 62, 1000, 10.1016/0002-9149(88)90537-1

Dunn, 1990, Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic, J Hypertens, 8, 775, 10.1097/00004872-199008000-00012

Alderman, 1995, Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men, Hypertension, 25, 1144, 10.1161/01.HYP.25.6.1144

Kahn, 1996, Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study, J Am Geriatr Soc, 44, 524, 10.1111/j.1532-5415.1996.tb01437.x

Verdecchia, 1998, Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension, J Am Coll Cardiol, 31, 383, 10.1016/S0735-1097(97)00493-2

Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203

Koren, 1991, Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension, Ann Intern Med, 114, 345, 10.7326/0003-4819-114-5-345

Muiesan, 1995, Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment, J Hypertens, 13, 1091, 10.1097/00004872-199510000-00003

Sokolow, 1961, The prognosis of essential hypertension treated conservatively, Circulation, 23, 697, 10.1161/01.CIR.23.5.697

Anonymous, 1974, Left ventricular hypertrophy patterns and prognosis: experience postinfarction in the Coronary Drug Project, Circulation, 49, 862, 10.1161/01.CIR.49.5.862

Behar, 1992, Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram, Am J Cardiol, 69, 985, 10.1016/0002-9149(92)90851-O

Sullivan, 1993, Left ventricular hypertrophy: effect on survival, J Am Coll Cardiol, 22, 508, 10.1016/0735-1097(93)90057-8

Larsen, 1994, Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia—its influence on diagnosis, triage, and short-term prognosis: a multicenter study, J Gen Intern Med, 9, 666, 10.1007/BF02599006

De Bacquer, 1998, Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women, Heart, 80, 570, 10.1136/hrt.80.6.570

Parfrey, 1990, The clinical course of left ventricular hypertrophy in dialysis patients, Nephron, 55, 114, 10.1159/000185937

Ghali, 1992, The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease, Ann Intern Med, 117, 831, 10.7326/0003-4819-117-10-831

Mensah, 1993, Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension, J Hypertens, 11, 1429, 10.1097/00004872-199312000-00016

Liao, 1995, Left ventricular hypertrophy has a greater impact on survival in women than in men, Circulation, 92, 805, 10.1161/01.CIR.92.4.805

Foley, 1995, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy, Kidney Int, 47, 186, 10.1038/ki.1995.22

Ganau, 1992, Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension, J Am Coll Cardiol, 19, 1550, 10.1016/0735-1097(92)90617-V

Devereux, 1993, What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry, Am J Hypertens, 6, 211

de Simone, 1994, Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults, Hypertension, 23, 600, 10.1161/01.HYP.23.5.600

Roman, 1996, Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults, J Am Coll Cardiol, 28, 751, 10.1016/0735-1097(96)00225-2

Verdecchia, 1995, Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass, J Am Coll Cardiol, 25, 871, 10.1016/0735-1097(94)00424-O

Verdecchia, 1996, Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy, Am J Cardiol, 78, 197, 10.1016/S0002-9149(96)90395-1

Krumholz, 1995, Prognosis of left ventricular geometric patterns in the Framingham Heart Study, J Am Coll Cardiol, 25, 879, 10.1016/0735-1097(94)00473-4

Ghali, 1998, Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease, J Am Coll Cardiol, 31, 1635, 10.1016/S0735-1097(98)00131-4

Liao, 1995, The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among blacks, JAMA, 273, 1592, 10.1001/jama.1995.03520440046035

Yurenev, 1992, Management of essential hypertension in patients with difference degrees of left ventricular hypertension: multicenter trial, Am J Hypertens, 5, 182, 10.1093/ajh/5.6.182S

Levy, 1994, Prognostic implicatins of baseline electrocardiographic features and their serial changes in subject with left ventricular hypertrophy, Circulation, 90, 1786, 10.1161/01.CIR.90.4.1786

Levy, 1987, Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study, Am J Cardiol, 9, 956, 10.1016/0002-9149(87)91133-7

de Simone, 1992, Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and of the impact of overweight, J Am Coll Cardiol, 20, 1251, 10.1016/0735-1097(92)90385-Z

de Simone, 1995, Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk, J Am Coll Cardiol, 25, 1056, 10.1016/0735-1097(94)00540-7

Liao, 1997, Prediction of mortality risk by different methods of indexation for left ventricular mass, J Am Coll Cardiol, 29, 641, 10.1016/S0735-1097(96)00552-9

Liu, 1999, Elevated ambulatory with normal clinic blood pressure (“white coat normotension”) is associated with cardiac and arterial target organ damage, Ann Intern Med, 131, 564, 10.7326/0003-4819-131-8-199910190-00003

Okin, 2000, Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study, Hypertension, 35, 13, 10.1161/01.HYP.35.1.13

Schillaci, 2000, Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension, Hypertension, 35, 580, 10.1161/01.HYP.35.2.580

Easterbrook, 1991, Publication bias in clinical research, Lancet, 337, 867, 10.1016/0140-6736(91)90201-Y

Devereux, 1996, Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials, J Hypertens, 14, S95, 10.1097/00004872-199609002-00018

Devereux, 1994, Criteria for an informative trial of left ventricular hypertrophy regression, J Hum Hypertens, 8, 735

Fleming, 1996, Surrogate end points in clinical trials: are we being misled?, Ann Intern Med, 125, 605, 10.7326/0003-4819-125-7-199610010-00011